Charles E. Bailey, MD AFFILIATIONS:
Executive DirectorGlobal Institute for Scientific ThinkingLake Mary, Florida
Medical DirectorAccurate Clinical TrialsKissimmee, Florida
Volunteer FacultyUniversity of Central Florida College of MedicineOrlando, Florida
PROFESSIONAL EXPERIENCE: Accurate Clinical Trials Principal Investigator and Medical Director
Oversees and directs all operations of Accurate Clinical Trials, Inc. Functions as Principal Investigatorfor inpatient clinical research psychopharmacology trials and provides clinical and medical oversight of study subjects. Provides Training to clinical staff and investigators regarding study conduct, protocol adherence, Good Clinical Practices, and responsible for establishing and maintaining effective corporate culture. CNS Healthcare Investigator and past Medical Director
Functions included serving as Principal Investigator and Sub Investigator for outpatientpsychopharmacology clinical research, providing clinical and medical oversight of study subjects. Osceola Community Mental Health Center
Outpatient Child and Adolescent Psychiatry
Seminole Community Mental Health Center
Outpatient Child and Adolescent Psychiatry
Lakeside Behavioral Health
Staff Psychiatrist, Day Treatment Program
Orlando Regional Behavioral Health Center
Medical Director, Outpatient Chemical Dependency
MCC Healthcare South Seminole Hospital South Seminole Hospital
Clinical Director, Inpatient Chemical Dependency Treatment
Lakewood Residential Treatment Center Rational Therapy Center EDUCATION:
University of Florida, Department of Psychiatry
University of Texas Health Science Center at Houston
Associate of Arts Baytown, TexasLee College 1977
LISCENSURE / ACCREDITATION:
Florida Medical License, June, 1985 - Present
Drug Enforcement Agency License, 1985 - Present
American Board of Psychiatry and Neurology, January, 1992 - Present
American Board of Addictions Medicine, June, 1993 - 2003
PROFESSIONAL AFFILIATIONS:
American Psychiatric Association 1985 – 2009
Florida Psychiatric Association, 1985 – 2009
Society for Neuroscience, 2004 – Present
CLINICAL EXPERIENCE:
General Psychiatry with diagnosis and treatment of DSM psychiatric disorders including medication,management, Rational Emotive and Cognitive Behavioral Therapies, 1985 - Present
EDUCATIONAL CONFERENCES:
AAPP: Good Clinical Practices for Clinical Investigators, 2001
Harvard Medical School: Attention Deficit/Hyperactivity Disorder, 2001
Harvard Medical School: Child and Adolescent Psychopharmacology, 1999 and 2000
Society for Neuroscience Annual Conference, 2004, 2005, 2006, 2007, and 2008
International Behavioral Neuroscience Annual Conference, 2006
Institute of General Semantics International Conference, 2006
New York Academy of Sciences Conference, Linking Affect to Action: Critical Contributions of the Orbitofrontal Cortex, 2007
The First International Conference on Social Entrepreneurship, Systems Thinking, and Complexity, 2008
Genetic and Evolutionary Computation Conference - GECCO 2008
2nd International Academy on Critical Thinking – Oxford UK 2008
The fourth Cold Spring Harbor Laboratory/Welcome Trust conference on Integrative Approaches to Brain Complexity, Hinxton/Cambridge UK 2008
New York Academy of Sciences, Values and Empathy across Social Barriers: A Neurocognitive Approach to Fairness, Barcelona, 2008
COSYNE 2009, Computational and Systems Neuroscience, Salt Lake City
RESEARCH FUNDING CONTRIBUTIONS: University of Central Florida School of Electrical Engineering and Computer Science Evolutionary Computation PUBLICATIONS:
Bailey, C. E. (2009). Exploiting the relationship of natural language and computer science: A novel
theoretical approach to fairness. Cognitive Sciences 4 (2): xx-xx.
Bailey, C. E. (2007). Semantically mediated integration of cognition in Homo sapiens: Evolution,
grammar, uncertainty, and cognitive accuracy. Cognitive Sciences 3 (1): 85-142.
Bailey, C. E. (2007). Cognitive accuracy and intelligent executive function in the brain and in business.
In C. Senior & M. J. R. Butler (Eds.), The social cognitive neuroscience of organizations. New York, NY: Annals of the New York Academy of Sciences, 1118, 122-141.
Bailey, C. E. (2006). A general theory of psychological relativity and cognitive evolution. ETC: A Review
Popper, C. W., Gammon, G. D., West, S. A. & Bailey, C. E. (2003). Disorders Usually First Diagnosed
in Infancy, Childhood, or Adolescence. In R. E. Hale & S. C. Yudofsky (Eds.). The Textbook of Clinical Psychiatry (4th Ed.). Washington, DC: American Psychiatric Publishing.
Spencer T, Kratochvil C, Sangal RB, Saylor K, Bailey C, Dunn D, Geller D, Casat C, Lipetz R, Jain R,
Newcorn J, Ruff D, Feldman P, Furr A, Allen AJ. Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment. J Child Adolesc Psychopharmacol 2007;17(5):689-699
Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder. Arch Pediatr Adolesc Med. 2006;160:82-90. ACKNOWLEDGEMENTS:
Lehman, J. & Stanley, K. (2008). Exploiting open-endedness to solve problems through the search for
novelty. In: Proceedings of the eleventh international conference on artificial life (ALIFE XI). Cambridge, MA: MIT Press
Kratochvil CJ, Michelson D, Newcorn J, Weiss M, Busner J, Moore R, Ruff D, Ramsey J, Dickson R,
Turgay A, Saylor K, Luber S, Vaughan B, Allen AJ, The Atomoxetine High-Dose Study Group. High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses. J Am Acad Child Adolesc Psychiatry. 2007;46(9):1128-1137
versus placebo in the acute treatment of major depression. J Psychiatr Res. 2002 Nov-Dec;36(6):383-90.
Douglas K. Kelsey, MD, PhD*, Calvin R. Sumner, MD*, Charles D. Casat, MD , Daniel L. Coury, MD ,
Humberto Quintana, MD||, Keith E. Saylor, PhD¶, Virginia K. Sutton, PhD*, Jill Gonzales, BS*, Sandra K. Malcolm, BS*, Kory J. Schuh, PhD* and Albert J. Allen, MD, PhD* . Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial. Pediatrics Vol. 114 No. 1 July 2004, pp. e1-e8 PRESENTATIONS:
Institute of General Semantics International Conference, Dallas, Texas, 2006, “Semantics: The Key to Understanding the Brain”
International Behavioral Neuroscience Annual Conference, Whistler, Canada, 2006, “A General Theory of Psychological Relativity and Cognitive Evolution”
The First International Conference on Social Entrepreneurship, Systems Thinking, and Complexity, New York, 2008, “Accurate Executive Function and Complexity: Something to Think About?”
The Society for Neuroscience 2008 annual conference Washington, D.C., “Semantically Mediated Integration of Cognition in Homo sapiens: Evolution, Grammar, Uncertainty, and Cognitive Accuracy”
New York Academy of Sciences, Values and Empathy across Social Barriers: A Neurocognitive Approach to Fairness, Barcelona, 2008, “Exploiting the Relationship of Natural Language and Computer Science: A Novel Theoretical Approach to Fairness”
ACNP, Scottsdale, 2008. Jain, R., Kollins, S., Bailey, C., Holloway, W., Horacek, J. & Khayrallah, M. “Developing a Sustained Release Formulation of Clonidine for the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder” (not attended)
PLASMA CLOZAPINE ASSAY REQUEST FORM Please send the completed form with a blood sample (at least 2 mL - collect into EDTA tube) to: Dr RJ Flanagan, Toxicology Unit, Bessemer Wing, King’s College Hospital, Denmark Hill, London SE5 9RS Tel: 020 3299 5881, Fax: 020 3299 5888, e-mail: kch-tr.toxicology@nhs.net *** Pack safely to Post Office regulations - Use KingsPath address
Target Campus Name: JOHN A BAKER T e x a s E d u c a t i o n A g e n c y Page 1 Target Campus #: 043912103 2007-08 Campus Comparison Group District Name: PROSPER ISD Campus Type: Elementary School Campus Campus District % % % % % % Number Name Name _White__ __Econ__ Afr_Amer Mobility Hispanic __LEP___ 021902112 SAM HOUSTON ELEMENTARY BRYAN ISD 75.0 23.1 11.8 11.9 12.9 0.2 037907100 R